Exact Mass: 355.944065
Exact Mass Matches: 355.944065
Found 25 metabolites which its exact mass value is equals to given mass value 355.944065,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Silver sulfadiazine
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BA - Sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
4-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)-3-iodobenzoic acid
C12H9IN2O3 (355.96579139999994)
1,3-adamantanediacetyl dichloride
C14H16Cl4O2 (355.99043559999996)
2-[(1,3-dioxoisoindol-2-yl)disulfanyl]isoindole-1,3-dione
5-Chloro-2-iodo-3-(5-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridine
2-[2-(ALLYLOXY)-1,1,2,2-TETRAFLUOROETHOXY]TETRAFLUOROETHANESULFONYL FLUORIDE
C7H5F9O4S (355.97648380000004)
7-Bromo-2-(chloroacetyl)-9,9-difluorofluorene
C15H8BrClF2O (355.94150720000005)
5-bromo-2-methoxy-N-(3-methyl-2-pyridinyl)benzenesulfonamide
C13H13BrN2O3S (355.9830208000001)
4-Bromo-3-(carboxymethoxy)-5-phenylthiophene-2-carboxylic acid
C13H9BrO5S (355.93540440000004)
CTPI-2
CTPI-2 is a third-generation mitochondrial citrate carrier SLC25A1 inhibitor with a KD of 3.5 μM. CTPI-2 inhibits glycolysis, PPARγ, and its downstream target the glucose transporter GLUT4. CTPI-2 halts salient alterations of NASH reverting steatosis, preventing the evolution to steatohepatitis, reducing inflammatory macrophage infiltration in the liver and adipose tissue, and starkly mitigating obesity induced by a high-fat diet. Antitumor activity[1][2].